“Car-T and Bispecific Antibodies for Refractory Non-Hodgkin Lymphoma: Long-Term Safety and Autoimmune Sequelae”. Journal of Carcinogenesis, vol. 24, no. 6s, Sept. 2025, pp. 805-20, https://doi.org/10.64149/J.Carcinog.24.6s.805-820.